Zymeworks Shares Rise Ahead of Key FDA Decision on Zanidatamab

Reported by Yahoo Finance · Published 24 Aug 2026, 6:48 PM MYT (1 d ago)

Summary

Source & full coverage: this summary is aggregated from Yahoo Finance, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at Yahoo Finance →

Most Recent

Tax tips for TikTok stars, after judge says influencer can’t write off his Grammy tickets 50 min ago Options traders are betting on the quietest Nvidia earnings reaction in years. It could be an opportunity for AI bulls. 54 min ago Intuit's annual forecast falls short of estimates as it prioritizes customer growth 58 min ago South Korea trade giant POSCO brings trade receivables to Avalanche in latest tokenization move 1 hr ago Has AI gotten any better at stock picking? 1 hr ago U.S.-Canada trade war threatens to worsen inflation for both economies. Neither can afford it. 1 hr ago

EconPulse

Markets. Economy. Malaysia & The World.

Independent economic news aggregation for Malaysia, Asia and global markets, updated throughout the day.

Company

About Us Editorial Standards & Corrections Privacy Policy

Work With Us

Submit a Press Release Partnerships & Advertising Contact Us RSS Feed

Contact

editor@econpulse.my

Editorial & newsroom enquiries answered within 1–2 business days.

Zymeworks Shares Rise Ahead of Key FDA Decision on Zanidatamab

Summary

More in Markets

Tax tips for TikTok stars, after judge says influencer can’t write off his Grammy tickets

Options traders are betting on the quietest Nvidia earnings reaction in years. It could be an opportunity for AI bulls.

Has AI gotten any better at stock picking?

U.S.-Canada trade war threatens to worsen inflation for both economies. Neither can afford it.

This chart shows exactly why investors should worry about rising yields — even if they don’t own any bonds

SpaceX to build Musk’s vision for a spaceport that until now ‘only existed in science fiction’